A B S T R A C T Previous studies have shown that plasma transcobalamin II (TCII) facilitates the cellular uptake of [57Co]vitamin B13 (Be) by a variety of tissues, but the lack of an intrinsic label on the protein moiety of the TCII-Bn complex has made it impossible to determine the role and fate of TCII during this process. We have labeled homogeneous rabbit and human TCII with 'I-labeled N-succinimidyl-3-(4-hydroxyphenyl) propionate and have performed in vivo experiments in rabbits.
INTRODUCTION
Human plasma contains three vitamin Bt (Bu)'-binding proteins, referred to (2-6) as transcobalamin I (TCI), transcobalamin II (TCII), and transcobalamin III (TCIII). TCI and TCIII are glycoproteins and belong to the group of immunologically similar proteins known as the R-type Bu-binding proteins (6) (7) (8) (9) (10) . Approximately 70-90% of the endogenous Bis in human plasma is bound to TCI (6, 11) , but ['Co]B22 bound to TCI is cleared slowly from human plasma with a ti of 9-12 days (12) . TCIII is derived from granulocytes (2, 6), contains less sialic acid than TCI (6) , and appears to circulate in vivo at a barely detectable level, less than 30% that of TCI (2, 6) . Both moieties of 'i-labeled human TCIII-['7Co]Bn are cleared rapidly (ti < 5 min) from rabbit plasma by the liver (13) by the mechanism described by Ashwell and Morell (14) for the clearance and catabolism of a wide variety of asialoglycoproteins. This observation suggests that TCIII might serve a scavenger function for Be released into areas of cell necrosis or infection. This function is compatible with the lack of any hematologic abnormalities in two brothers with apparent congenital deficiencies of all sponds only to large frequent injections of B12 (21) . TCJJ contains only 10-20% (6, 11) of the endogenous BR in human plasma, but approximately 70% of ["7Co]B12 bound to human TCJI is cleared from human plasma in the 10 min after injection (12) . During the following hours, ti values for clearance have been estimated in the range of 1 h (22) to 12 h (12) . The lack of a label on the protein moiety of TCII-B12 has made it impossible to determine whether the early rapid plasma clearance of [57Co]B12 is due to an unusually large extracellular fluid distribution of TCII-[57Co] B12 or whether the slow, late clearance of [7Co]Bn2 is due to recirculation of the ["7Co ]B12 molecule. To elucidate the role and fate of TCIJ in the plasma transport of B12, we have labeled rabbit and human TCII with 'I and have studied the plasma clearances of these proteins in the presence and absence of [67Co]Bn2 in rabbits. METHODS Protein preparations. Human TCII was isolated from Cohn fraction III of normal human plasma, as described previously (5) , except that the preparation employed here was isolated from a different batch of Cohn fraction III.
When a 20 pug of this second preparation of human TCII was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis in the presence of 1%o 2-mercaptoethanol, a single protein band was observed, with an apparent mol wt of 38,000. This differs from the original preparation, which gave two protein bands with apparent mol wts of 38 ,000 and 25,000 (5) . The significance of this difference will be discussed elsewhere. 2 The two preparations were otherwise identical in terms of amino acid composition, amino acid content relative to B12, lack of carbohydrate, absorption spectra, apparent mol wt (38,000) based on gel filtration at low TCII concentrations (< 10 pg/ml), yield (15%o ), and overall purification (2,000,000-fold relative to plasma).
Rabbit TCII was isolated from 20 liters of rabbit serum (type 2 from 1-3-yr-old rabbits, Pel-Freez Bio-Animals, Inc., Rogers, Ark.) by a purification scheme consisting of affinity chromatography on B12-Sepharose, chromatography on DEAE-cellulose, and gel filtration on Sephadex G-150. These purification techniques were performed essentially as described for human TCII (5) , and details will be presented elsewhere. 2 The final preparation was purified 40,000-fold relative to serum, with a yield of 31%o, and gave a single band on sodium dodecyl sulfate polyacrylamide gel electrophoresis with an apparent mol wt of 40,000. Purified rabbit TCII gave a single precipitin line on immunodiffusion against chicken anti-human TCII with a pattern of partial identity to human TCII.
Labeling of proteins with "UI and "'I. N-Succinimidyl Bn2) was incubated with 0.5 pug of the same preparation of "I-labeled ester in a volume of 50 Al. "2I-labeled ester was prepared as described above for the 'I-labeled ester. Approximately 0.20 mol of 13"I was coupled per mol of ester. Rabbit TCII and human TCII were labeled with 121I-labeled ester as described above for 'I. Bovine serum albumin (type V, Sigma Chemical Co.), 5 pg, was incubated with 0.25 pug of .3.I-labeled ester in a volume of 10 pl.
Removal and replacement of Bi2. The low-specific-activity [57Co]EB2 (<0.03 pCi/jug), bound to 'I and 'I-labeled rabbit and human TCII, was removed (> 99%) by dialysis of the entire sample at room temperature for 72 h against 15 vol of 0.1 M potassium phosphate, pH 7.5, containing 7.5 M guanidine-HCl, with dialysate changes after 24 and 48 h. A twofold excess of high-specific-activity ['Co] Bja (15 pCi/,ug) was added to aliquots of the dialyzed protein samples, and each sample was adjusted to contain 5.0 M guanidine-HCl in a volume of 1.5 ml. The samples were then dialyzed against 550 ml of 0.01 M potassium phosphate, pH 7.5, containing 0.14 M NaCl for 16 h at 40C. Thereafter, samples were adjusted to contain 0.25 mg bovine serum albumin, 0.05 M potassium phosphate, pH 7.5, and 0.75 M NaCl in a volume of 2.5 ml and were applied to a column (2.0 cm diameter by 60 cm in height) of Sephadex G-150 'equilibrated at 40C with 0.05 M potassium phosphate, pH 7.5 and 0.75 M NaCl. Fractions of 3.0 ml were collected in glass test tubes that contained 300 pg of bovine serum albumin in 150 Al of equilibrating solution. The bovine serum albumin served to reduce the adsorption of 'I-and 'I-labeled proteins to glass. Appropriate fractions (see "Results") were pooled and stored in 5-ml aliquots at -20°. ' 7 .5, 0.75 M NaCl, containing 71 mg of polyethylene glycol (mol wt=6000, Union Carbide Corp., New York) was added. After standing for 15 min, the tubes were centrifuged at 6,000 g for 15 min, and 500 pl of the supernatant liquid was assayed for 'I. Under these conditions, 60%o of the "2I-labeled human TCII-B11 precipitated in the absence of unlabeled human TCII-B12. This value fell significantly and progressively to 10% as the amount of unlabeled human TCII-B1n was increased over the range from 2 to 60 ng of protein. Additional details, including the observation that immunoreactive TCII is absent from the plasma of two patients with congenital TCII deficiency, will be presented elsewhere.'
Other methods. Gel filtration on Sephadex G-150 (24), Ba-binding assays (24) , B12 assays (6), sodium dodecyl sulfate polyacrylamide gel electrophoresis (24) , immunization of animals (8), immunodiffusion (8) , immunoprecipitation assays (9) , and the preparation of Bu-Sepharose (25) (6, 11) . (5) . The molar ratios of 'I to rabbit and human TCII devoid of B12 were not significantly different from those observed with their 'lI-labeled TCII counterparts based on B12 binding assays performed with the mI-labeled preparations.
Plasma survival of ...I-labeled rabbit TCII-[`7Co]Bis. When "SI-labeled rabbit TCII-[57Co]B12 and 'I-labeled bovine serum albumin were simultaneously injected intravenously into a rabbit, the three isotopes were cleared from the plasma and excreted in the urine as shown in Fig. 2 . The '21I disappeared slowly from the plasma at a rate compatible with the equilibration of albumin with the extracellular fluid; 65% of the total amount of 'I administered was present in the plasma 240 min after the injection. Approximately 5% of the 'I was excreted in the urine during this time. Similar results were obtained with similarly labeled human transferrin in other experiments (data not presented). During the first 60 min after the injection, 'Co and 'I disappeared from the plasma at identical rates faster than that of "KI. From 60 to 240 min, the plasma disappearance rate of 'TCo decreased, and 25% of the 6'Co remained in the plasma at the end of this time. Less than 1% of the 'Co was excreted in the urine during the 240 min period. After 60 min, the 'I continued its initial rapid disappearance from the plasma, and only 15% remained after 240 min. After a delay of 30 min, large amounts of 'I appeared in the urine; 42% of the administered amount had been excreted at the end of 240 min. The peak period of urinary excretion occurred at 60-100 min.
From the assumption that the difference between the plasma survival of 'I and 'I represents the tissue uptake of 'I that is not attributable to diffusion into the extracellular fluid, a ti of approximately 90 min was estimated for this process. This value also holds for 'TCo during the initial 60 min after the injection of 'I-labeled rabbit TCII-['Co] B12.
Properties of 1"I in the urine, and '"I and 'Co in the plasma after the intravenous injection of "I-labeled rabbit TCII-['Co]B.,. When a sample of pooled urine obtained from the experiment shown in Fig. 2 was subjected to gel filtration on Sephadex G-150, all of the 'I eluted in a single peak with an apparent mol wt of less than 1,000 (data not presented), suggesting that a significant portion of the MI-labeled rabbit TCII had been degraded during the experiment. Although the kidney is responsible for its excretion, at least a major part of this low-molecular-weight material must be formed by other tissues, since it was present in significant amounts in a 240-min plasma sample obtained from a rabbit nephrectomized 1 h before the injection of MI-labeled rabbit TCII-[tCo]Bn. The elution profile of this plasma sample is presented in Fig. iD and reveals that essentially 100% of the 'Co, but only 50% of the 'I, eluted with an apparent mol wt of 40,000, the same as that of the starting material (seen Fig. IC) . More than 90% of the 'I and 'Co in this position were precipitated by chicken anti-human TCII serum; less than 10% were adsorbed by But-Sepharose. Approximately 40% and 10% of the plasma 'I eluted with apparent mol wts of less than 1,000, and 70,000, respectively. None of the 'I in either position was precipitated by chicken antihuman TCII serum or adsorbed by Bu-Sepharose. The nature of the 'I in the less than 1,000 mol wt region has not been determined, although free 'I and 'I-labeled N-succinimidyl-3-(4-hydroxyphenyl) propionate, either free or attached to one or a few amino acids, are likely possibilities. The nature of the 'I in the 70,000-mol-wt region is also unknown, although the 'I appears to be covalently bound to some component, possibly rabbit albumin, since it was not dialysable when the plasma was dialyzed against 1% sodium dodecyl sulfate or 7.5 M guanidine-HCl containing 1% 2-mercaptoethanol. The fact that similar material has been observed (13) after the intravenous injections of 'I-la- unnephrectomized rabbits were also studied by gel filtration. These studies revealed that the ratio of 'I to 'MCo in the 40,000 apparent mol wt region was equal to the preinjection ratio in the 5-and 30-min samples and declined progressively in the 60-to 1,440-min. samples. All of the 'Co in each sample was located in the apparent 40,000-mol-wt region. The lowmol-wt 'I-material was not detectable in the 5-and 30-min plasma samples. It was present in greatest absolute and relative (10% of plasma 'I) amount in the 60-min sample, and declined thereafter. The 'I with an apparent mol wt of 70,000 was first detected in the 60-min sample, where it accounted for 1% of the total 'I; it slowly increased subsequently and accounted for 5% of the total 'I in the 240-min sample. More than 90% of the 'I in these samples eluted with an apparent mol wt of 70,000, the same as that of the 'I-labeled bovine serum albumin in the starting sample. Tissue, rather than plasma or blood cells alone, appears to be required for the formation of the low-mol-wt 'I-material, since when 5-min plasma and whole blood Table I ) of data obtained from five rabbits sacrificed 30 min after injection. Small but significant differences between the contents of 'I and 'Co were observed in the heart and lung. These differences could be due either to early release of 'I from these organs or to insufficient adjustment for the decrease in counting efficiency for 'I in these organs, since 'I-labeled rabbit TCII might not have the same intraorgan distribution as the 'Ilabeled bovine serum albumin upon which the adjustments were based, as described under Methods. The net tissue uptake of 'I and 'Co at 30 min was actually somewhat greater than that shown in Fig. 3 and Table  I , since all of the tissues were contaminated by plasma containing 'I, present in approximately 20% excess of I5 and 'Co. Plasma survival and tissue distribution of apo-and holo-rabbit TCII. When 'I-labeled rabbit TCII devoid of B1s was mixed with 'mI-labeled rabbit TCII-['TCo]B1, and injected intravenously into a rabbit, the 'I disappeared from the plasma 30% faster than the 'I, and more 'I than 'I was excreted in the urine during the 240-min course of the experiment, as shown in Fig. 4 . When the 'I-labeled rabbit TCII was saturated with unradioactive Bn before this experiment was repeated, the plasma survivals and urinary excretions of '5I and 'I were no longer distinguishable from each other (data not presented). All of the urinary 'I and 'I in these experiments had an apparent mol wt of less than 1,000 based on gel filtration.
Data concerning the tissue distributions of 'I, 'I, and "7Co 30 min after the simultaneous intravenous injection of 'I-labeled rabbit TCII and 'I-labeled rabbit TCII-[57Co]Bn are presented in Table II . The failure to find marked differences in the ratio of 'I to 'I in the tis- Five rabbits were injected. Statistical analysis employed the Student t test and was based on the assumption that log 1251/1311, etc. were normally distributed. The ratios were calculated on the basis of the percent of the total amount of each isotope administered. * The value differs from 1.00 at P < 0.01. The value differs from 1.00 at P < 0.05.
sues examined indicates that apo-and holo-rabbit under these conditions of continuous saturation of TCII with B12, the 'I was cleared rapidly from the plasma at its usual rate and 45% of the 'I was excreted in the urine during the 240-min course of the experiment.
Comparison of rabbit TCII and human TCII. When 'I-labeled human TCII-['Co] B1 was mixed with 'Ilabeled rabbit TCII-B12 and injected intravenously into a rabbit, the "2I was cleared from the plasma and excreted in the urine faster than the 'I, as shown in Fig.  5 . When "2I-labeled human TCII-[1TCo]B1 was mixed with native rabbit TCII-['CO]Bn and injected intravenously into a rabbit, 'Co was cleared from the plasma faster than 'Co, as shown in Fig. 6 . The rabbit utilized for this experiment was sacrificed 240 min after the injection, and the tissue distributions of 'Co and 'Co were determined. The data are presented in Table III and reveal marked differences in the ratio of '7Co to 'Co in individual tissues. This observation suggests that individual tissues may vary in the degree with which they take up B1 bound to human and rabbit TCII. No firm conclusions can be reached in this regard, however, since some or all of the differences in the ratio of 'Co to 'Co could be due to differences in the recirculation of 'Co rabbit, the 'I was cleared from the plasma approximately 30% faster than the 'I, as shown in Fig. 7 . The urinary excretion of 'I also proceeded faster than that of 'I. All of the 'I and 'I in the urine had an apparent mol wt of less than 1,000, based on gel filtration. Plasma survival of human TCII as determined by radioimmunoassay. Purified but unlabeled human TCII-B. (24 ug of protein and 0.74 lig of B12) was mixed with MI-labeled bovine serum albumin and injected intravenously into a rabbit. The amount of TCII-Ba injected increased the rabbit's total plasma TCII-Bt. concentration by approximately 15%. The content of human TCII in plasma samples obtained from 5 to 1,440 min after injection was assayed by a radioimmunoassay specific for human TCII, as compared with rabbit TCII, since the antiserum was raised in rabbits. The plasma survival data are presented in Fig. 8 and reveal that the plasma survival of unlabeled human TCII based on the radioimmunoassay was essentially the same as that determined with 'I-labeled human TCII (compare Fig.   8 with Figs. 5, 6, and 7). The same result was obtained when this experiment was repeated with a second rabbit. These observations are consistent with the concept that TCII is degraded after its uptake by tissues and make it extremely unlikely that the small-mol-wt 'Imaterial is formed by mere elution of the 'I from the TCII molecule.
DISCUSSION
The studies presented here demonstrate that rabbit and human TCII can be covalently labeled with PI-or I- Hepatic uptake is effected by the mechanism elucidated by Ashwell and Morell (14) , in which glycoproteins containing terminal galactose residues bind to hepatocyte plasma membrane receptors, enter cells in intact form, presumably by pinocytosis, and are subsequently degraded by lysosomal enzymes. In the case of 'I-labeled B22-binding protein [tmCo]B12 complexes mentioned above, the 'I reappears in the plasma in low-mol-wt (less than 1,000) form 30 min after hepatic uptake and is rapidly excreted in the urine, while 70-80% of the 'Co reenters the plasma from 60 to 180 min after uptake and is present bound to rabbit TCII. The similarity between the kinetics of these phenomena and those observed with "SI-labeled TCII-[5Co] B, suggests that the entire TCII-B22 complex may be taken up by a variety of cells by pinocytosis and that the TCII moiety may be degraded subsequently by lysosomal enzymes. Evidence in support of this possibility has been obtained by Pletsch and Coffey (27, 28) in studies that involved the subcellular fractionation of rat liver at various times after the intravenous injection of ['Co]Bu bound rapidly in vivo by rat plasma TCII. The availability of MI-labeled TCII should enhance future studies of this kind.
The rapid turnover of TCII appears to place an unnecessary metabolic burden on the body, although it is important to note that this burden is relatively minor, since TCII accounts for only 0.0025% and 0.00005% of the total protein present in rabbit and human plasma, respectively. It is possible that TCII must be degraded to free the tightly bound B1a molecule (affinity constant = 1022M-' [29] ) for intracellular use, although protein degradation is not involved in the cellular uptake of iron from transferrin, despite the fact that the affinity constant for iron and transferrin is of the order of 10mM-
